{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T05:03:31Z","timestamp":1648789411518},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1981,4,1]],"date-time":"1981-04-01T00:00:00Z","timestamp":354931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[1981,4]]},"DOI":"10.1007\/bf00408229","type":"journal-article","created":{"date-parts":[[2004,10,25]],"date-time":"2004-10-25T16:44:11Z","timestamp":1098722651000},"page":"171-173","source":"Crossref","is-referenced-by-count":3,"title":["Hepatic acetylator phenotype in porphyria cutanea tarda"],"prefix":"10.1007","volume":"270","author":[{"given":"J. M.","family":"Ladero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Enriquez","family":"de Salamanca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Chinarro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1172\/JCI108560","volume":"58","author":"JP Kushner","year":"1976","unstructured":"Kushner JP, Barbuto AJ, Lee GR (1976) An inherited enzymatic defect in porphyria cutanea tarda: Decreased uroporphyrinogen decarboxylase activity. J Clin Invest 58:1089?1097","journal-title":"J Clin Invest"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/cs0580477","volume":"58","author":"GH Elder","year":"1980","unstructured":"Elder GH, Sheppard DM, Enriquez de Salamanca R, Olmos A (1980) Identification of two types of porphyria cutanea tarda by measurement of erythrocyte uroporphyrinogen decarboxylase. Clin Sci 58:477?484","journal-title":"Clin Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF00406542","volume":"269","author":"L Llorente","year":"1980","unstructured":"Llorente L, Enriquez de Salamanca R, Campillo F, Pe\u00f1a ML (1980) HLA and porphyria cutanea tarda. Arch Dermatol Res 269:209?210","journal-title":"Arch Dermatol Res"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000250524","volume":"160","author":"P Santoianni","year":"1980","unstructured":"Santoianni P, De Felice M, Ayala F, Budillon G, Zappacosta S (1980) A novel association between HLA and disease: Porphyria cutanea tarda and HLA-AW 32. Dermatologica 160:371?375","journal-title":"Dermatologica"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.2.5197.485","volume":"2","author":"DAP Evans","year":"1960","unstructured":"Evans DAP, Manley KA, McKusick VA (1960) Genetic control of isoniazid metabolism in man. Brit Med J 2:485?491","journal-title":"Brit Med J"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jmg.6.4.405","volume":"6","author":"DAP Evans","year":"1969","unstructured":"Evans DAP (1969) An improved and simplified method of detecting the acetylator phenotype. J Med Gen 6:405?407","journal-title":"J Med Gen"},{"key":"CR7","volume-title":"Practical clinical biochemistry","author":"H Varley","year":"1962","unstructured":"Varley H (1962) Practical clinical biochemistry, 3rd edn. Heinemann, London","edition":"3rd edn."},{"key":"CR8","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/cpt1977223251","volume":"22","author":"DE Drayer","year":"1977","unstructured":"Drayer DE, Reidenberg MM (1977) Clinical consequences of polymorphic acetylation of basic drugs. Clin Pharmacol Ther 22:251?258","journal-title":"Clin Pharmacol Ther"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.0954-6820.1977.tb15686.x","volume":"201","author":"R Larsson","year":"1977","unstructured":"Larsson R, Karlsson E, Molin L (1977) Spontaneous systemic lupus erythematosus and acetylator phenotype. Acta Med Scand 201:223?226","journal-title":"Acta Med Scand"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/art.1780230508","volume":"23","author":"MM Reidenberg","year":"1980","unstructured":"Reidenberg MM, Levy M (1980) Acetylator phenotype in idiopatic systemic lupus erythematosus. Arthritis Rheum 23:569?573","journal-title":"Arthritis Rheum"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/art.1780220714","volume":"22","author":"RJ Morris","year":"1979","unstructured":"Morris RJ, Freed CR, Kohler PF (1979) Drug acetylation phenotype unrelated to development of spontaneous systemic lupus erythematosus. Arthritis Rheum 22:777?779","journal-title":"Arthritis Rheum"},{"key":"CR12","first-page":"29","volume":"7","author":"M Oka","year":"1978","unstructured":"Oka M, Sepp\u00e4l\u00e4 O (1978) Acetylation phenotype in rheumatoid arthritis. Scand J Rheumatol 7:29?30","journal-title":"Scand J Rheumatol"},{"key":"CR13","first-page":"196","volume":"2","author":"GE Ehrlich","year":"1979","unstructured":"Ehrlich GE, Freeman-Narrod M, Wineburgh GS (1979) Predominance of slow acetylators among patients with rheumatoid arthritis. Eur J rheumatol Inflam 2:196?198","journal-title":"Eur J rheumatol Inflam"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bmj.2.6082.291","volume":"2","author":"EH McLaren","year":"1977","unstructured":"McLaren EH, Burden AC, Moorhead PJ (1977) Acetylator phenotype in diabetic neuropathy. Br Med J 2:291?293","journal-title":"Br Med J"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1136\/bmj.1.6107.208","volume":"1","author":"AW Burrows","year":"1978","unstructured":"Burrows AW, Hockaday TDR, Mann JI, Taylor JG (1978) Diabetic dimorphism according to acetylator status. Br Med J 1:208?210","journal-title":"Br Med J"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1136\/bmj.2.6080.155","volume":"2","author":"F Farah","year":"1977","unstructured":"Farah F, Taylor W, Raelins MD, James O (1977) Hepatic drug acetylation and oxidation: effects of aging in man. Br Med J 2:155?156","journal-title":"Br Med J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(68)92292-7","volume":"1","author":"AJ Levi","year":"1968","unstructured":"Levi AJ, Sherlock S, Walker D (1968) Phenylbutazone and isoniazid metabolism in patients with liver disease in relation to previous drug therapy. Lancet 1:1275?1279","journal-title":"Lancet"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00408229.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00408229\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00408229","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:12:07Z","timestamp":1554336727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00408229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1981,4]]},"references-count":17,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1981,4]]}},"alternative-id":["BF00408229"],"URL":"https:\/\/doi.org\/10.1007\/bf00408229","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1981,4]]}}}